Back to Top

"UnitedHealth ventures deeper into care with nearly $5B deal"

 

"Charitable foundations offer a critical safety net to underinsured patients"

 

 "Prostatepedia: Conversations With Prostate Cancer Experts"

 

"Need Help With Medical Bills?"

 

Patient Access Network Foundation Opens New Acute Myeloid Leukemia Patient Assistance Fund

 

For Immediate Release

PAN Foundation Contact:

Margaret Figley, Director of Communications

E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

Washington, DC, (June 16, 2017) - The Patient Access Network (PAN) Foundation today opened a new patient assistance program for Medicare patients with acute myeloid leukemia (AML). Qualifying patients are eligible to receive grants for their out-of-pocket costs associated with their prescribed AML medications.

“The PAN Foundation is pleased to support people living with acute myeloid leukemia,” said PAN President and CEO Daniel Klein. “When people—and their families—receive a diagnosis like AML, the financial implications can be tremendous. We are committed to finding ways to ease those financial burdens, so that people living with acute myeloid leukemia can focus on feeling better, getting through their treatments and hopefully recovering.”

Patients who qualify for the PAN Foundation’s AML program are eligible to receive up to $5,500 per year in financial assistance. Eligible patients must be getting treatment for AML; must reside and receive treatment in the United States; must have Medicare health insurance; and the medication for which they seek assistance must be covered by Medicare and must treat the disease directly. In addition, patients must fall at or below 500 percent of the Federal Poverty Level.

Patients, or advocates and caregivers applying on their behalf, can apply for assistance using the PAN Foundation’s online patient portal (www.panapply.org), or by calling 1-866-316-7263, 9 a.m. to 5 p.m. Eastern Time, Monday through Friday. To learn more about PAN’s more than 50 disease-specific programs, visit panfoundation.org.

 

About the PAN Foundation:

The PAN Foundation is an independent, nationwide 501(c)3 organization dedicated to providing help and hope to underinsured patients who are unable to afford the out-of-pocket expenses for their prescribed medications. Since 2004, PAN has provided over $2.5 billion in financial assistance to more than 700,000 patients who would otherwise be unable to afford their medications. To learn more, visit www.panfoundation.org.

 

 

 

"BioPlus Specialty Pharmacy’s ‘Pay It Forward’ Program Donates $250,000 to Patient Programs"

 

"More Americans rely on handouts for affordable medication"

 

"Patients' annual financial burden under Medicare Part D is 'too much too soon'"

 

"Supplements | Beyond Charitable Assistance: Sustainable Strategies for Providing Access to Critical Medications"

 

"Addressing Patient Needs Around the Cost of Care"

 

Patient Access Network Foundation and MPN Advocacy and Education International Announce New Alliance to Provide Support for People Living With Myeloproliferative Neoplasms

 

For Immediate Release

PAN Foundation Contact:

Margaret Figley, Director of Communications

E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

Washington, DC, (February 23, 2017) - The Patient Access Network (PAN) Foundation and MPN Advocacy and Education International today announced they are launching a new alliance to offer a broad range of support for people living with myeloproliferative neoplasms (MPNs). Working together, the PAN Foundation and MPN Advocacy and Education International will ensure that people living with MPNs have access to both financial assistance and patient support services, providing them with the holistic support to best manage their disease.

“At PAN, we are committed to decreasing some of the financial burden that patients and families face with diseases like myeloproliferative neoplasms,” said PAN President and CEO Dan Klein. “But we know that financial concerns are just part of the challenge. In working with MPN Advocacy and Education International, we can connect patients to additional services like educational symposiums, free webcasts, collateral materials and more.”

According to MPN Advocacy and Education International, myeloproliferative neoplasms are a group of rare blood cancers in which the bone marrow becomes overactive, causing the cells to develop and function abnormally. There are three main MPNs: myelofibrosis, polycythemia vera and essential thrombocythemia.

“We are excited to launch this alliance with the PAN Foundation, and provide another layer of support for our patients and families,” said MPN Advocacy and Education International CEO Ann Brazeau. “Because MPNs are rare, receiving an MPN diagnosis is particularly stressful. We aim to support the MPN community in any way we can, and by working with PAN we can help remove cost barriers for many patients, allowing them to focus on their health.”

Patients who qualify for the PAN Foundation’s MPN program are eligible to receive up to $12,000 per year in financial assistance. Eligible patients must be getting treatment for MPN; must reside and receive treatment in the United States; must have health insurance; and the medication for which they seek assistance must be covered by their health insurance and must treat the disease directly. In addition, patients must fall at or below 500 percent of the Federal Poverty Level.

Patients, or advocates and caregivers applying on their behalf, can apply for assistance using the PAN Foundation’s online patient portal (www.panapply.org), or by calling 1-866-316-7263, 9 a.m. to 5 p.m. Eastern Time, Monday through Friday. To learn more about PAN’s more than 50 disease-specific programs, visit panfoundation.org.

 

About the PAN Foundation:

The PAN Foundation is an independent, nationwide 501(c)3 organization dedicated to providing help and hope to underinsured patients who are unable to afford the out-of-pocket expenses for their prescribed medications. Since 2004, PAN has provided over $2.5 billion in financial assistance to more than 700,000 patients who would otherwise be unable to afford their medications. To learn more, visit www.panfoundation.org.

 

About MPN Advocacy and Education International:

MPN Advocacy and Education International is dedicated to providing the knowledge, support and resources patients will need as they adjust to living with an MPN through educational symposia in several cities each year, website access, free webcasts of each program, collateral materials and direction to people, resources and other organizations that can help.

 

 

Patient Access Network Foundation and Multiple Sclerosis Association of America Announce New Alliance to Provide Support for People Living With Multiple Sclerosis

 

For Immediate Release

PAN Foundation Contact:

Margaret Figley, Director of Communications

Phone: 202-661-8074

E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

Washington, DC, (February 9, 2017) - The Patient Access Network (PAN) Foundation and Multiple Sclerosis Association of America (MSAA) today announced they are launching a new alliance to offer a broad range of support for people living with multiple sclerosis (MS). Working together, the PAN Foundation and MSAA will ensure that people living with multiple sclerosis have access to both financial and patient support services, providing them with the holistic support needed to best manage their disease.

“While our work at PAN centers on alleviating the financial hardship for patients and families who face diseases like multiple sclerosis, we recognize that financial assistance is only one piece of the puzzle,” said PAN President and CEO Dan Klein. “In partnering with MSAA, we can connect patients to additional services and resources, including educational programs, safety and mobility equipment, cooling products, MRI funding, and technology and tools that can help them achieve healthier outcomes.”

According to MSAA, multiple sclerosis is a disease of the central nervous system, which consists of the brain, optic nerves and spinal cord. MS damages or destroys the protective covering surrounding the nerves of the central nervous system and can potentially injure the nerves themselves. This damage causes reduced communication between the brain and nerve pathways. An estimated 2.5 million people worldwide are living with MS.

“We are excited that our new alliance with PAN will allow MSAA to expand the services we provide to more people living with MS,” said MSAA President and CEO Gina Ross Murdoch. “An MS diagnosis can be overwhelming not only for the individuals who are diagnosed, but also for their loved ones. Our partnership with PAN will mitigate some of the financial pressures so that patients can focus on how to best manage their disease.”

Patients who qualify for the PAN Foundation’s multiple sclerosis program are eligible to receive up to $8,000 per year in financial assistance. Eligible patients must be getting treatment for MS; must reside and receive treatment in the United States; must have Medicare health insurance; and the medication for which they seek assistance must be covered by Medicare and must treat the disease directly. In addition, patients must fall at or below 500 percent of the Federal Poverty Level.

Patients, or advocates and caregivers applying on their behalf, can apply for assistance using the PAN Foundation’s online patient portal (www.panapply.org), or by calling 1-866-316-7263, 9 a.m. to 5 p.m. Eastern Time, Monday through Friday. To learn more about PAN’s more than 50 disease-specific programs, visit panfoundation.org.

 

About the PAN Foundation:

The PAN Foundation is an independent, nationwide 501(c)3 organization dedicated to providing help and hope to underinsured patients who are unable to afford the out-of-pocket expenses for their prescribed medications. Since 2004, PAN has provided over $2.5 billion in financial assistance to more than 700,000 patients who would otherwise be unable to afford their medications. To learn more, visit www.panfoundation.org.

About the Multiple Sclerosis Association of America:

The Multiple Sclerosis Association of America (MSAA) is a national nonprofit organization and leading resource for the entire MS community, improving lives today through vital services and support. MSAA provides free programs and services, such as: a Helpline with trained specialists; award-winning publications, including MSAA’s magazine, The Motivator; MSAA’s nationally recognized website (at mymsaa.org), featuring award-winning educational videos and research updates; S.E.A.R.C.H.™ program to assist the MS community with learning about different treatment choices; a mobile phone app, My MS Manager™ (named one of the best multiple sclerosis iPhone & Android apps by Healthline.com); a resource database, My MS Resource Locator®; safety and mobility equipment distribution; cooling accessories for heat-sensitive individuals; educational programs held across the country; MRI funding; My MSAA Community, a peer-to-peer online support forum; and more. For additional information, please visit www.mymsaa.org or call (800) 532-7667.

 

 

Patient Access Network Foundation and ThyCa: Thyroid Cancer Survivors’ Association Announce New Alliance to Provide Support for People Living With Thyroid Cancer

 

For Immediate Release

PAN Foundation Contact:

Margaret Figley, Director of Communications

Phone: 202-661-8074

E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

Washington, DC, (January 26, 2017) - The Patient Access Network (PAN) Foundation and ThyCa: Thyroid Cancer Survivors’ Association, Inc. (ThyCa) today announced they are launching a new alliance to offer a broad range of support for people living with thyroid cancer. Working together, the PAN Foundation and ThyCa will ensure that people living with thyroid cancer have access to both financial and patient support services, providing them with the holistic support needed to best manage their disease.

“Here at PAN, our goal is to help ease some of the financial stress for patients and families facing diseases like thyroid cancer,” said PAN President and CEO Dan Klein. “But we know that financial concerns are just one part of the challenge. In partnering with ThyCa, we can connect patients to additional services and resources, including handbooks and publications, support groups, clinical trial information and more.”

Thyroid cancer, a cancerous tumor or growth located within the thyroid gland, is the most common endocrine cancer, according to ThyCa. Thyroid cancer is one of the few cancers that has increased in incidence rates over recent years. It occurs in all age groups from children through seniors.

“We are thrilled to work with PAN, and to provide extended support to our patients and families,” said ThyCa Executive Director Gary Bloom. “This alliance will connect us to even more patients in need, expanding the number we are able to help, and hopefully alleviating some of the financial pressures that come with the diagnosis, treatment and management of thyroid cancer.”

Patients who qualify for the PAN Foundation’s thyroid cancer program are eligible to receive up to $12,000 per year in financial assistance. Eligible patients must be getting treatment for thyroid cancer; must reside and receive treatment in the United States; must have Medicare health insurance; and the medication for which they seek assistance must be covered by Medicare and must treat the disease directly. In addition, patients must fall at or below 500 percent of the Federal Poverty Level.

Patients, or advocates and caregivers applying on their behalf, can apply for assistance using the PAN Foundation’s online patient portal (www.panapply.org), or by calling 1-866-316-7263, 9 a.m. to 5 p.m. Eastern Time, Monday through Friday. To learn more about PAN’s more than 50 disease-specific programs, visit panfoundation.org.

 

About the PAN Foundation:

The PAN Foundation is an independent, nationwide 501(c)3 organization dedicated to providing help and hope to underinsured patients who are unable to afford the out-of-pocket expenses for their prescribed medications. Since 2004, PAN has provided over $2.5 billion in financial assistance to more than 700,000 patients who would otherwise be unable to afford their medications. To learn more, visit www.panfoundation.org.

 

About ThyCa:

ThyCa: Thyroid Cancer Survivors' Association, Inc. is a non-profit 501(c)(3) organization of thyroid cancer survivors, family members, and health care professionals, dedicated to support, education, and communication for thyroid cancer survivors, their families and friends. ThyCa also sponsors Thyroid Cancer Awareness Month, year-round awareness activities, and thyroid cancer research fundraising and research grants. For more information, visit www.thyca.org.

 

 

Patient Access Network Foundation and Us TOO Announce New Alliance to Provide Support for People Living With Prostate Cancer

 

For Immediate Release

PAN Foundation Contact:

Margaret Figley, Director of Communications

Phone: 202-661-8074

E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

Washington, DC, (January 26, 2017) - The Patient Access Network (PAN) Foundation and Us TOO International today announced they are launching a new alliance to offer a broader range of support for the prostate cancer community. Working together, the PAN Foundation and Us TOO will ensure that people living with prostate cancer have access to a combination of educational resources and financial support services to more effectively manage their disease.

 “At PAN, we aim to alleviate some of the financial burden facing patients and families with diseases like prostate cancer,” said PAN President and CEO Dan Klein. “Our alliance with Us TOO will help us expand that support beyond financial assistance alone. Together, we can connect patients to additional services, including educational materials and resources, local support groups, information on treatment options and more.”

Prostate cancer is the most common non-skin cancer among men in the United States, according to Us TOO. Every year more than 230,000 men are diagnosed with prostrate cancer, and approximately 30,000 die from the disease. If detected early, prostate cancer is often treatable.

“We are excited to work with PAN and expand the impact of the educational resources and support services we currently offer at no charge to prostate cancer patients and their families,” said Us TOO CEO Chuck Strand. “This alliance helps to address the needs of a growing prostate cancer population in the United States, which is currently more than 2.9 million and is estimated to reach 4.2 million men by the year 2024 as the baby boomer generation ages.”

Patients who qualify for the PAN Foundation’s prostate cancer program are eligible to receive up to $12,000 per year in financial assistance. Eligible patients must be getting treatment for prostate cancer; must reside and receive treatment in the United States; must have Medicare health insurance; and the medication for which they seek assistance must be covered by Medicare and must treat the disease directly. In addition, patients must fall at or below 500 percent of the Federal Poverty Level.

Patients, or advocates and caregivers applying on their behalf, can apply for assistance using the PAN Foundation’s online patient portal (www.panapply.org), or by calling 1-866-316-7263, 9 a.m. to 5 p.m. Eastern Time, Monday through Friday. To learn more about PAN’s more than 50 disease-specific programs, visit panfoundation.org.

 

About the PAN Foundation:

The PAN Foundation is an independent, nationwide 501(c)3 organization dedicated to providing help and hope to underinsured patients who are unable to afford the out-of-pocket expenses for their prescribed medications. Since 2004, PAN has provided over $2.5 billion in financial assistance to more than 700,000 patients who would otherwise be unable to afford their medications. To learn more, visit www.panfoundation.org.

 

About Us TOO International Prostate Cancer Education and Support Network:

Us TOO International is a 501(c)3 nonprofit that serves the prostate cancer community by providing educational materials and resources at no charge. The organization was founded by—and continues to be governed by—people directly affected by prostate cancer. Us TOO develops digital and printed educational materials and support services that include more than 200 volunteer-led support groups, the Us TOO website (www.ustoo.org), online communities, toll-free HelpLine (1-800-808-7866), and the monthly distribution of Hot SHEET newsletter and Prostate Cancer News You Can Use, in addition to educational/awareness events.

 

 

PAN Foundation Featured in Forbes’ 100 Largest U.S. Charities

 

The PAN Foundation is featured in Forbes’ 100 Largest U.S. Charities for 2016 list, ranking as the fourteenth largest charity in the country.

"Myeloma Survivor Shares Insights on Adherence to Oral Anticancer Medications"

 

 

 

Patient Access Network Foundation and the Cutaneous Lymphoma Foundation Announce New Alliance to Provide Support for People Living With Cutaneous T-Cell Lymphoma

 

For Immediate Release

PAN Foundation Contact:

Margaret Figley, Director of Communications

Phone: 202-661-8074

E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

Washington, DC, (October 20, 2016) - The Patient Access Network (PAN) Foundation and the Cutaneous Lymphoma Foundation (CLF) today announced they are launching a new alliance to offer a broad range of support for people living with cutaneous T-cell lymphoma. Working together, the PAN Foundation and the CLF will ensure that people living with cutaneous T-cell lymphoma have access to helpful resources and both patient and financial support services, providing them with the holistic support to best manage their disease.

“Here at PAN, our goal is to provide financial support to patients facing diseases like cutaneous T-cell lymphoma,” said PAN President and CEO Dan Klein. “Our partnership with the Cutaneous Lymphoma Foundation helps us take that support a step further, by connecting patients and families to enhanced services like personalized support, in-person networking groups, an online learning center and live educational events.”

Cutaneous lymphomas, a subset of non-Hodgkin’s lymphoma, are cancers of lymphocytes (white blood cells) that primarily involve the skin, according to the Cutaneous Lymphoma Foundation. Classification is based on lymphocyte type: B-lymphocytes (B-cell) or T-lymphocytes (T-cell). Cutaneous T-cell lymphoma is the most common type of cutaneous lymphoma.

“We are thrilled to work with PAN and expand our services to our patients and their families,” said CLF CEO Susan Thornton. “A cutaneous T-cell lymphoma diagnosis is understandably overwhelming for patients and their loved ones. Our partnership with PAN allows us to help alleviate some of the financial pressures so they can focus on what matters most—their health.”

Patients who qualify for the PAN Foundation’s cutaneous T-cell lymphoma program are eligible to receive up to $20,000 per year in financial assistance. Eligible patients must be getting treatment for cutaneous T-cell lymphoma; must reside and receive treatment in the United States; must have health insurance; and the medication for which they seek assistance must be covered by their health insurance and must treat the disease directly. In addition, patients must fall at or below 500 percent of the Federal Poverty Level.

Patients, or advocates and caregivers applying on their behalf, can apply for assistance using the PAN Foundation’s online patient portal (www.panapply.org), or by calling 1-866-316-7263, 9 a.m. to 5 p.m. Eastern Time, Monday through Friday. To learn more about PAN’s more than 50 disease-specific programs, visit panfoundation.org.

About the PAN Foundation:

The PAN Foundation is an independent, nationwide 501(c)3 organization dedicated to providing help and hope to underinsured patients who are unable to afford the out-of-pocket expenses for their prescribed medications. Since 2004, PAN has provided over $2.5 billion in financial assistance to more than 700,000 patients who would otherwise be unable to afford their medications. To learn more, visit www.panfoundation.org.

About the Cutaneous Lymphoma Foundation: 

The Cutaneous Lymphoma Foundation is an independent, non-profit patient advocacy organization dedicated to supporting every person affected by cutaneous lymphoma by promoting awareness and education, advancing patient care and fostering research for the best possible outcomes. For more information, visit clfoundation.org or call 1-248-644-9014.

 

 

"Daniel J. Klein Discusses the Importance of the PAN Challenge" 

 

 

 

Patient Access Network Foundation and the National Parkinson Foundation Announce New Alliance to Provide Support for People Living With Parkinson’s Disease

 

For Immediate Release

PAN Foundation Contact:

Margaret Figley, Director of Communications

Phone: 202-661-8074

E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

Washington, DC, (October 20, 2016) - The Patient Access Network (PAN) Foundation and the National Parkinson Foundation (NPF), a division of the Parkinson’s Foundation, today announced they are launching a new alliance to offer a broad range of support for people living with Parkinson’s disease. Working together, the PAN Foundation and the NPF will ensure that people living with Parkinson’s disease have access to both financial and patient support services, providing them with the holistic support needed to best manage their disease.

“At PAN, we work to alleviate some of the financial burden that patients and families face with diseases like Parkinson’s,” said PAN President and CEO Dan Klein. “But we know that financial concerns are just part of the challenge faced by people with Parkinson’s. In working with the National Parkinson Foundation, we can connect patients to additional services, including a national helpline, educational materials, online forums with experts, a resource library and more.”

According to the American Academy of Neurology, Parkinson’s disease affects about 1 million Americans, with at least 60,000 new cases reported each year.

“We are excited to kick off this partnership with the PAN Foundation, and provide extended support for our patients and families,” said Paul Blom, Interim CEO of the National Parkinson Foundation, a division of the Parkinson’s Foundation. “Parkinson’s disease is a complex, long-term disease that can be stressful and overwhelming for patients and their families. By partnering with PAN, we can help to ease some of the financial pressure for those who need it most.”

Patients who qualify for the PAN Foundation’s Parkinson’s Disease program are eligible to receive up to $16,500 per year in financial assistance. Eligible patients must be getting treatment for Parkinson’s Disease; must reside and receive treatment in the United States; must have Medicare health insurance; and the medication for which they seek assistance must be covered by Medicare and must treat the disease directly. In addition, patients must fall at or below 500 percent of the Federal Poverty Level.

Patients, or advocates and caregivers applying on their behalf, can apply for assistance using the PAN Foundation’s online patient portal (www.panapply.org), or by calling 1-866-316-7263, 9 a.m. to 5 p.m. Eastern Time, Monday through Friday. To learn more about PAN’s more than 50 disease-specific programs, visit panfoundation.org.

About the PAN Foundation:

The PAN Foundation is an independent, nationwide 501(c)3 organization dedicated to providing help and hope to underinsured patients who are unable to afford the out-of-pocket expenses for their prescribed medications. Since 2004, PAN has provided over $2.5 billion in financial assistance to more than 700,000 patients who would otherwise be unable to afford their medications. To learn more, visit www.panfoundation.org.

About the National Parkinson's foundation, a division of the Parkinson's Foundation: 

The Parkinson’s Foundation is working toward a world without Parkinson’s disease.  Formed by the merger of National Parkinson Foundation (NPF) and the Parkinson’s Disease Foundation (PDF) in August 2016, the mission of the Parkinson’s Foundation is to invest in promising scientific research that will end Parkinson’s disease and improve the lives of people with Parkinson’s and their families, through improved treatments, support and the best care. For more information, visit www.parkinson.org  or call 1-800-473-4636.

 

 

 

"Avoiding Cost-Based Nonadherence"